Analysis of lifetime death probability for major causes of death among residents in China

Ping Yuan, Jianjun Xiang, Matthew Borg, Tiehui Chen, Xiuquan Lin, Xiane Peng, Kuicheng Zheng, Ping Yuan, Jianjun Xiang, Matthew Borg, Tiehui Chen, Xiuquan Lin, Xiane Peng, Kuicheng Zheng

Abstract

Background: Cumulative mortality rate and cumulative mortality risk are two commonly used indicators to measure the impact and severity of diseases. However, they are calculated during a defined life span and assume the subject does not die from other causes. This study aims to use a new indicator, lifetime death probability (LDP), to estimate the lifetime death probabilities for the top five leading causes of death in China and explore the regional differences and trends over time.

Methods: LDPs were calculated using a probability additive formula and abridged life tables.

Results: In 2014, LDPs for heart disease, cerebrovascular disease, malignancy, respiratory disease, and injury and poisoning were 24.4, 23.7, 19.2, 15.5, and 5.3%, respectively. The LDPs for heart disease and malignancy increased by 7.3 and 0.5%, respectively, compared to those from 2004 to 2005. In contrast, the LDPs for cerebrovascular and respiratory disease decreased by 1.0 and 3.9%, respectively, compared to those in 2004-2005. Across the eastern, central and western regions, malignancy had the highest LDP in the eastern region, cerebrovascular and heart diseases in the central region, and respiratory diseases, and injury and poisoning in the western region.

Conclusions: LDP is an effective indicator for comparing health outcomes and can be applied for future disease surveillance. Heart disease and malignancy were the two most common causes of death in China, but with regional differences. There is a need to implement targeted measures to prevent chronic diseases in different regions.

Keywords: Cause of death; Chronic diseases; Lifetime death probability; Mortality.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Yang J, Feng L, Zheng Y, Yu H. Estimation on the indirect economic burden of disease-related premature deaths in China, 2012. Chin J Epidemiol. 2014;35:1256–1262.
    1. China Center for Disease Control and Prevention and Statistical Information Center of National Health and Family Planning Commission . Chinese death surveillance data set (2014) Beijing: Popular Science Press; 2015. pp. 244–248.
    1. Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;394:1145–1158.
    1. Alexander K, Florian F, Dietrich P, Paulo P, Li L, Yuanyuan S, et al. Burden of disease in China contrasting disease burden patterns of the general and the migrant workers populations. 2014.
    1. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012;41:861–870.
    1. Latouche A, Allignol A, Beyersmann J, Labopin M, Fine J. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol. 2013;66:648–653.
    1. Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res. 2007;13:559–565.
    1. Zhou T, Chen C. An indicator of death-cause composition-a life-time death probability. China Health Stat. 1998;8:45–46.
    1. Sun Z, Xu Y. Health medical statistics. Beijing: People's Health Publishing House; 2006. pp. 377–381.
    1. Inoue M, Tominaga S. Probabilities of developing cancer over the life span of a Japanese-update. Asian Pac J Cancer Prev. 2003;4:199–202.
    1. Silcocks PB, Jenner DA, Reza R. Life expectancy is a summary of mortality in a population: statistical considerations and suitability for use by health authorities. J Epidemiol Community Health. 2001;55:38–43.
    1. Yuan P, Chen TH, Chen ZW, Lin XQ. Calculation of life-time death probability due to malignant tumors based on a sampling survey area in China. Asian Pac J Cancer Prev. 2014;15:4307–4309.
    1. Hao J, Chen W. Chinese cancer registry annual report in 2012. Military Med Sci Press. 2012:10–3.
    1. Yuan P, Chen TH, Lin XQ. Comparison of life-time death probability due to malignant tumors in different regions of China based on Chinese surveillance sites. Asian Pac J Cancer Prev. 2019;20:2021–2025.
    1. Zhang H. A new theory about additive formula in probability. Southwest University for nationalities. Natural Science Edition. 2010;36:544–546.
    1. Chen Z. The third national restrospective sampling survey report on the cause of death. Beijing: Beijing Union Medical University Press; 2008. pp. 52–53.
    1. Liu S, Wu X, Lopez AD, Wang L, Cai Y, Page A, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ. 2016;94:46–57.
    1. Kohl M, Plischke M, Leffondré K, Heinze G. PSHREG. A SAS macro for proportional and nonproportional subdistribution hazards regression. Comput Methods Prog Biomed. 2015:218–33.
    1. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990-2010: findings from the global burden of disease study 2010. Lancet. 2013;381:1987–2015.
    1. Kong LZ. China's medium-to-long term plan for the prevention and treatment of chronic diseases (2017-2025) under the healthy China initiative. Chronic Dis Transl Med. 2017;3(3):135–137.
    1. Chen YS, Xu SX, Ding YB, Huang XE, Deng B, Gao XF, et al. Colorectal cancer screening in high-risk populations: a survey of cognition among medical professionals in Jiangsu, China. Asian Pac J Cancer Prev. 2014;14(11):6487–6491.
    1. Wang Y, Yu YH, Shen K, Xiao L, Luan F, Mi XJ, et al. Cervical cancer screening and analysis of potential risk factors in 43,567 women in Zhongshan, China. Asian Pac J Cancer Prev. 2014;15(2):671–676.
    1. Ren G, Ye J, Fan Y, Wang J, Sun Z, Jia H, et al. Survey and analysis of awareness of lung cancer prevention and control in a LDCT lung cancer screening project in Tianjin Dagang oil field of China. Chin J Lung Cancer. 2014;17(2):163–170.
    1. Chen X, Gui G, Ji W, Xue Q, Wang C, Li H. The relationship between obesity subtypes based on BMI and cardio-cerebrovascular disease. Hypertens Res. 2019;42(6):912–919.
    1. Ortega FB, Lavie CJ. Introduction and update on obesity and cardiovascular diseases 2018. Prog Cardiovasc Dis. 2018;61(2):87–88.
    1. Lu J, Bi Y, Wang T, Wang W, Mu Y, Zhao J, et al. The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study. Int J Cardiol. 2014;172(2):388–394.
    1. Zhang X, Zhang M, Zhao Z, Huang Z, Deng Q, Li Y, et al. Geographic variation in prevalence of adult obesity in China: results from the 2013-2014 national chronic disease and risk factor surveillance. Ann Intern Med. 2020;172:291–293.
    1. Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the global burden of disease study 2013. Lancet. 2016;387(10015):251–272.
    1. Diederich S. Respiratory disease caused by exposure to biomass fuels. Eur Radiol. 2003;13(10):2247–2248.
    1. Kurmi OP, Semple S, Simkhada P, Smith WC, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010;65(3):221–228.
    1. Ezzati M, Kammen DM. Quantifying the effects of exposure to indoor air pollution from biomass combustion on acute respiratory infections in developing countries. Environ Health Perspect. 2001;109(5):481–488.
    1. Fu H, Feng D, Tang S, He Z, Xiang Y, Wu T, et al. Prevalence of tobacco smoking and determinants of success in quitting smoking among patients with chronic diseases: a cross-sectional study in rural western China. Int J Environ Res Public Health. 2017;14(2):167.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren